LQN — Latex Agglutination Assay, Rubella Class II

FDA Device Classification

FDA product code LQN covers "Latex Agglutination Assay, Rubella", a Class II medical device regulated under 21 CFR 866.3510. Submissions are reviewed by the Microbiology panel. At least 13 recent 510(k) clearances have been granted under this product code.

Classification Details

Product Code
LQN
Device Class
Class II
Regulation Number
866.3510
Submission Type
510(k)
Review Panel
MI
Medical Specialty
Microbiology
Implant
No

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K031490Immunostics IncRUBELLACOLJul 16, 2003
K970931Sienna BiotechCOPALIS TORC TOTAL ANTIBODY ASSAYApr 24, 1997
K961784Sienna BiotechCOPALIS ONE IMMUNOASSAY SYSTEM/TOXOPLASMA GONDII/RUBELLA/CMV TOTAL ANTIBODY…Oct 31, 1996
K954920Murex DiagnosticsMUREX RUB-EXAug 21, 1996
K952544SeradynCOLORSLIDER RUBELLAJan 17, 1996
K912391OrionRUBALEX, MODIFICATIONMay 4, 1992
K901637OrionRESUBMITTED MODIFIED RUBALEXApr 26, 1990
K896433Biokit UsaMODIFIED RUBAGENNov 29, 1989
K893755Biokit UsaRUBAGENAug 21, 1989
K861881OrionRUBALEX (REVISED VERSION)Jun 4, 1986
K852788OrionRUBALEXMar 12, 1986
K844436ArmkelVIROGEN RUBELLA MICROTITER TESTMay 21, 1985
K844435ArmkelVIROGEN RUBELLA SLIDE TESTMay 20, 1985

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.